GE Healthcare and Geron Announce Exclusive Global Agreement to Commercialize Stem Cell Drug Discovery Technologies
Geron Press Release “CHALFONT ST. GILES, UK & MENLO PARK, Calif., June 30, 2009 – GE Healthcare, a unit...Geron Press Release
“CHALFONT ST. GILES, UK & MENLO PARK, Calif., June 30, 2009 – GE Healthcare, a unit of General Electric Company (NYSE: GE), and Geron Corporation (Nasdaq: GERN) today announced that they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells (hESCs) for use in drug discovery, development and toxicity screening.”
Read More »